177 related articles for article (PubMed ID: 31087189)
1. The incidence of consecutive manifestations in Von Hippel-Lindau disease.
van der Horst-Schrivers ANA; Sluiter WJ; Kruizinga RC; van Leeuwaarde RS; Giles R; Olderode-Berends MJW; Links TP
Fam Cancer; 2019 Jul; 18(3):369-376. PubMed ID: 31087189
[TBL] [Abstract][Full Text] [Related]
2. Calculating optimal surveillance for detection of von Hippel-Lindau-related manifestations.
Kruizinga RC; Sluiter WJ; de Vries EG; Zonnenberg BA; Lips CJ; van der Horst-Schrivers AN; Walenkamp AM; Links TP
Endocr Relat Cancer; 2014 Feb; 21(1):63-71. PubMed ID: 24132471
[TBL] [Abstract][Full Text] [Related]
3. New von Hippel-Lindau manifestations develop at the same or decreased rates in pregnancy.
Binderup ML; Budtz-Jørgensen E; Bisgaard ML
Neurology; 2015 Oct; 85(17):1500-3. PubMed ID: 26408493
[TBL] [Abstract][Full Text] [Related]
4. Neurologic manifestations of von Hippel-Lindau disease.
Butman JA; Linehan WM; Lonser RR
JAMA; 2008 Sep; 300(11):1334-42. PubMed ID: 18799446
[TBL] [Abstract][Full Text] [Related]
5. Retinal hemangioblastoma in von Hippel-Lindau disease: a clinical and molecular study.
Dollfus H; Massin P; Taupin P; Nemeth C; Amara S; Giraud S; Béroud C; Dureau P; Gaudric A; Landais P; Richard S
Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):3067-74. PubMed ID: 12202531
[TBL] [Abstract][Full Text] [Related]
6. The impact of molecular genetic analysis of the VHL gene in patients with haemangioblastomas of the central nervous system.
Gläsker S; Bender BU; Apel TW; Natt E; van Velthoven V; Scheremet R; Zentner J; Neumann HP
J Neurol Neurosurg Psychiatry; 1999 Dec; 67(6):758-62. PubMed ID: 10567493
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics of ocular angiomatosis in von Hippel-Lindau disease and correlation with germline mutation.
Webster AR; Maher ER; Moore AT
Arch Ophthalmol; 1999 Mar; 117(3):371-8. PubMed ID: 10088816
[TBL] [Abstract][Full Text] [Related]
8. Genotype-phenotype analysis of von Hippel-Lindau syndrome in Korean families: HIF-α binding site missense mutations elevate age-specific risk for CNS hemangioblastoma.
Lee JS; Lee JH; Lee KE; Kim JH; Hong JM; Ra EK; Seo SH; Lee SJ; Kim MJ; Park SS; Seong MW
BMC Med Genet; 2016 Jul; 17(1):48. PubMed ID: 27439424
[TBL] [Abstract][Full Text] [Related]
9. Genotype-phenotype correlation in von Hippel-Lindau disease.
Reich M; Jaegle S; Neumann-Haefelin E; Klingler JH; Evers C; Daniel M; Bucher F; Ludwig F; Nuessle S; Kopp J; Boehringer D; Reinhard T; Lagrèze WA; Lange C; Agostini H; Lang SJ
Acta Ophthalmol; 2021 Dec; 99(8):e1492-e1500. PubMed ID: 33720516
[TBL] [Abstract][Full Text] [Related]
10. Two Childhood Pheochromocytoma Cases due to von Hippel-Lindau Disease, One Associated with Pancreatic Neuroendocrine Tumor: A Very Rare Manifestation.
Dağdeviren Çakır A; Turan H; Aykut A; Durmaz A; Ercan O; Evliyaoğlu O
J Clin Res Pediatr Endocrinol; 2018 Jun; 10(2):179-182. PubMed ID: 29022557
[TBL] [Abstract][Full Text] [Related]
11. Genetic study of a large Chinese kindred with von Hippel-Lindau disease.
Huang YR; Zhang J; Wang JD; Fan XD
Chin Med J (Engl); 2004 Apr; 117(4):552-7. PubMed ID: 15109448
[TBL] [Abstract][Full Text] [Related]
12. VON HIPPEL-LINDAU DISEASE: Update on Pathogenesis and Systemic Aspects.
Aronow ME; Wiley HE; Gaudric A; Krivosic V; Gorin MB; Shields CL; Shields JA; Jonasch EW; Singh AD; Chew EY
Retina; 2019 Dec; 39(12):2243-2253. PubMed ID: 31095066
[TBL] [Abstract][Full Text] [Related]
13. Management recommendations for pancreatic manifestations of von Hippel-Lindau disease.
Laks S; van Leeuwaarde R; Patel D; Keutgen XM; Hammel P; Nilubol N; Links TP; Halfdanarson TR; Daniels AB; Tirosh A;
Cancer; 2022 Feb; 128(3):435-446. PubMed ID: 34735022
[TBL] [Abstract][Full Text] [Related]
14. Ocular clusterin expression in von Hippel-Lindau disease.
Zhou M; Shen D; Head JE; Chew EY; Chévez-Barrios P; Green WR; Chan CC
Mol Vis; 2007 Nov; 13():2129-36. PubMed ID: 18079682
[TBL] [Abstract][Full Text] [Related]
15. von Hippel-Lindau disease: Diagnosis and factors influencing disease outcome.
Binderup MLM
Dan Med J; 2018 Mar; 65(3):. PubMed ID: 29510814
[TBL] [Abstract][Full Text] [Related]
16. [Von Hippel-Lindau disease].
Takahashi K; Iida K; Chihara K
Nihon Rinsho; 2006 Sep; Suppl 3():351-4. PubMed ID: 17022562
[No Abstract] [Full Text] [Related]
17. Retinal hemangioblastoma: prevalence, incidence and frequency of underlying von Hippel-Lindau disease.
Binderup MLM; Stendell AS; Galanakis M; Møller HU; Kiilgaard JF; Bisgaard ML
Br J Ophthalmol; 2018 Jul; 102(7):942-947. PubMed ID: 28972023
[TBL] [Abstract][Full Text] [Related]
18. Manifestations of Von Hippel Lindau syndrome: a retrospective national review.
O' Brien FJ; Danapal M; Jairam S; Lalani AK; Cunningham J; Morrin M; McNally S; Donovan MG; Little D; Tuthill A; Conlon PJ
QJM; 2014 Apr; 107(4):291-6. PubMed ID: 24352051
[TBL] [Abstract][Full Text] [Related]
19. Hemangioblastomas of the central nervous system in von Hippel-Lindau syndrome and sporadic disease.
Conway JE; Chou D; Clatterbuck RE; Brem H; Long DM; Rigamonti D
Neurosurgery; 2001 Jan; 48(1):55-62; discussion 62-3. PubMed ID: 11152361
[TBL] [Abstract][Full Text] [Related]
20. [Clinicopathologic study of von Hippel-Lindau syndrome-related and sporadic hemangioblastomas of central nervous system].
Zhou J; Li NY; Zhou XJ; Zhou HB; Wu B; Jiang SJ; Ma HH; Zhang RS
Zhonghua Bing Li Xue Za Zhi; 2010 Mar; 39(3):145-50. PubMed ID: 20450758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
